Announce Date | 04/24/2025 |
EPS Normalized Actual | $2.86 (Beat by $0.76) |
EPS GAAP Actual | $2.86 (Beat by $0.76) |
Revenue Actual | $0.97B |
Revenue Surprise | Beat by $970M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $2.32 |
EPS GAAP Estimate | $2.32 |
Revenue Estimate | $0.95247526B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 6.84 | 8.83 | 6.46674 | 7.23791 | 1 |
Dec 2026 | 6.62 | 9.12 | 5.47777 | 7.32225 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 2.81 | 2.81 | 0.97B | 30.93% | 970M |
FQ4 2024 (Dec 2024) | 0.14 | 0.14 | 1.627B | 37.49% | 1627M |
FQ3 2024 (Sep 2024) | 0.0402 | 0.0402 | 1.277B | -1.88% | 1277M |
FQ2 2024 (Jun 2024) | 2.68 | 2.68 | 1.228B | 2.52% | 1228M |
FQ1 2024 (Mar 2024) | 2.73 | 2.73 | 0.67B | -99.25% | 670M |
FQ4 2023 (Dec 2023) | 1.3 | 1.3 | 1.017B | -81.61% | 1017M |
FQ3 2023 (Sep 2023) | 3.43 | 3.43 | 1.301B | 6.38% | 1301M |
FQ2 2023 (Jun 2023) | 0.96 | 0.96 | 1.197B | 10.36% | 1197M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
2.32
Consensus Revenue Estimates
0.95247526B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.87 | -- | 1.75967 | 1.95812 | 4 |
FQ3 2027 (Sep 2027) | 4.64 | -- | 4.36624 | 4.85866 | 3 |
FQ2 2027 (Jun 2027) | 1.66 | -- | 1.56206 | 1.73823 | 4 |
FQ1 2027 (Mar 2027) | 4.38 | -- | 4.12158 | 4.58641 | 3 |
FQ4 2026 (Oct 2026) | 2.68 | -- | 2.18178 | 2.94844 | 3 |
FQ3 2026 (Jul 2026) | 2.96 | -- | 2.40973 | 3.25649 | 5 |
FQ2 2026 (Jun 2026) | 1.26 | -- | 1.20097 | 1.32188 | 3 |
FQ1 2026 (Mar 2026) | 3.19 | 11.91 | 3.04054 | 3.34667 | 6 |
FQ4 2025 (Oct 2025) | 2.83 | 95.05 | 2.3039 | 3.11347 | 4 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.15B | -- | 1.09B | 1.19B | 6 |
FQ3 2027 (Sep 2027) | 1.18B | -- | 1.13B | 1.22B | 3 |
FQ2 2027 (Jun 2027) | 1.05B | -- | 1.01B | 1.09B | 3 |
FQ1 2027 (Mar 2027) | 1.06B | -- | 1.01B | 1.1B | 3 |
FQ4 2026 (Oct 2026) | 1.05B | -- | 0.9B | 1.13B | 4 |
FQ3 2026 (Jul 2026) | 0.94B | -- | 0.81B | 1.02B | 5 |
FQ2 2026 (Jun 2026) | 0.94B | -- | 0.91B | 0.98B | 6 |
FQ1 2026 (Mar 2026) | 0.96B | -0.62 | 0.93B | 1B | 4 |
FQ4 2025 (Oct 2025) | 0.98B | -66.78 | 0.84B | 1.05B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 2.81 | 2.81 | 100% | |
FQ4 2024 (Dec 2024) | 0.14 | 0.14 | 100% | |
FQ3 2024 (Sep 2024) | 0.0402 | 0.0402 | 100% | |
FQ2 2024 (Jun 2024) | 2.68 | 2.68 | 100% | |
FQ1 2024 (Mar 2024) | 2.73 | 2.73 | 100% | |
FQ4 2023 (Dec 2023) | 1.3 | 1.3 | 100% | |
FQ3 2023 (Sep 2023) | 3.43 | 3.43 | 100% | |
FQ2 2023 (Jun 2023) | 0.96 | 0.96 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $0.97B | $970M | 100% |
FQ4 2024 (Dec 2024) | $0B | $1.63B | $1627M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.28B | $1277M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.23B | $1228M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.67B | $670M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.02B | $1017M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.3B | $1301M | 100% |
FQ2 2023 (Jun 2023) | $0B | $1.2B | $1197M | 100% |